StockNews.com Initiates Coverage on Fortress Biotech (NASDAQ:FBIO)

StockNews.com assumed coverage on shares of Fortress Biotech (NASDAQ:FBIO – Get Rating) in a research report released on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other research analysts have also weighed in on FBIO. Cantor Fitzgerald cut their target price on Fortress Biotech from $6.00 to $5.00 in […]

Related Keywords

,Advisor Group Holdings Inc ,Morgan Stanley ,Charles Schwab Investment Management Inc ,Connor Clark Lunn Investment Management Ltd ,Fortress Biotech Inc ,Cantor Fitzgerald ,Wells Fargo Company ,Biotechnology Product Development ,Fortress Biotech ,Get Rating ,Moderate Buy ,Group Holdings ,Schwab Investment Management ,Lunn Investment Management ,Wells Fargo ,Dermatology Product Sales ,Fortress Biotech Daily ,Nasdaq Fbio ,Fbio ,Medical ,21976u10 ,Initiated Coverage ,Stocknews Com ,